Boston Scientific Corporation (FRA:BSX)
Germany
· Delayed Price · Currency is EUR 88.20
+0.60 (0.68%)
Aug 14, 2025, 5:15 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Other | -1.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| MedSurg | 5.99B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| MedSurg Growth | 12.58% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiovascular | 10.76B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiovascular Growth | 26.71% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rhythm & Neuro | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rhythm & Neuro Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | -1.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| MedSurg Income Before Taxes | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| MedSurg Income Before Taxes Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiovascular Income Before Taxes | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiovascular Income Before Taxes Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rhythm & Neuro Income Before Taxes | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rhythm & Neuro Income Before Taxes Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| MedSurg Organic Revenue Growth | 7.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rhythm & Neuro Organic Revenue Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiovascular Organic Revenue Growth | 21.90% |
Log In |
Log In |
Log In |
Log In | Upgrade
|